Open to any pharmaceutical, life sciences or medical device company operating in the UK and Europe, this award will go to the company that can demonstrate outstanding customer-centric achievement across its entire product range.
This category can both be entered directly and be nominated. To be eligible for the Company of the Year award companies must submit a minimum of one entry in any of the other PMEA categories. It would be advantageous to enter as many of the previous PMEA categories as are appropriate, to be able to provide well-rounded examples of excellent work across the company.
While sustained achievements are important, judges will be appraising the company’s performance from January 2024 to June 2025.
To enter directly, you should submit via the online entry portal following the criteria on this page.
If being asked to enter, following the review of all the entries, the judging panel will draw up a shortlist of companies.. Judges will also consider year-on-year performance data from IQVIA.
The judges will be looking for exceptional companies, with broad expertise and skills. The companies will have excellent customer/stakeholder/patient focus, be innovative and forward-looking, with strong cross-functional working.
Shortlisted companies will be invited to put together a short video against a brief, write an essay (if not entered directly) following the criteria. The companies will then be asked to attend a question & answer session to a select judging panel on Friday 7 November 2025. This date cannot be changed, therefore keep this available as we are unable to offer any alternatives. Q&A will be conducted via Zoom at 30-minute intervals during the day. Please provide details on the entry system as to whom should be contacted if you/your client is shortlisted.
